schiff has invested in Ganeden Biotech, Inc.
| Target Company Name |
Ganeden Biotech, Inc. |
|---|---|
| Target Country |
USA |
| Description | Capital Raise for a U.S. based developer of proprietary probiotic strains |
| Global M&A Offices |
Brown Gibbons Lang & Company
(Global M&A USA)
|
| Global M&A Advisory | Advisor |
